← Back to Search

Parathyroid patients for Adenoma

Phase 4

Recruiting

Led By Herbert Chen, MD

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

age greater than 18 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 20 minutes

Awards & highlights

Study Summary

This trial tests if a special dye can help make thyroid and parathyroid surgery safer and more accurate.

Who is the study for?

This trial is for adults over 18 who need thyroid or parathyroid surgery. It's not suitable for those with allergies to iodine, shellfish, or indocyanine green, nor for pregnant individuals.Check my eligibility

What is being tested?

The study tests if using a special dye called indocyanine green and a portable imaging device can help surgeons better identify and protect the parathyroid glands during surgery.See study design

What are the potential side effects?

Potential side effects may include allergic reactions to the indocyanine green dye. However, since this is used externally with imaging equipment, risks are generally low.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 20 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~20 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percentage of Parathyroid Glands identified by ICG

Trial Design

1Treatment groups

Experimental Treatment

Group I: Parathyroid patientsExperimental Treatment2 Interventions

patients who require parathyroid identification and preservation during parathyroid surgery maneuver

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Indocyanine green

2016

Completed Phase 4

~1720

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor

1,590 Previous Clinical Trials

2,281,245 Total Patients Enrolled

1 Trials studying Adenoma

40 Patients Enrolled for Adenoma

Stryker NordicIndustry Sponsor

32 Previous Clinical Trials

3,678 Total Patients Enrolled

Herbert Chen, MDPrincipal InvestigatorUniversity of Alabama at Birmingham

4 Previous Clinical Trials

366 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the Food and Drug Administration sanctioned treatments for those with Parathyroid conditions?

"As this therapeutic approach is an approved Phase 4 trial, our team at Power has judged its safety to be 3 on a scale of 1-3."

Answered by AI

Is there an open enrollment period for participation in this research study?

"Clinicaltrials.gov indicates that recruitment for this particular trial has concluded, as the initial posting was dated January 1st 2024 and the last update occurred on December 5th 2023. Nevertheless, there are 85 other studies actively enrolling participants at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation

Herbert Chen 2024. "Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06169735.